跳至主要内容
临床试验/ACTRN12613000046707
ACTRN12613000046707已完成4 期

Inflammometry in people with Chronic Obstructive Pulmonary Disease (COPD) and its impact on health related quality of life and COPD exacerbations.

John Hunter Hospital0 个研究点目标入组 134 人开始时间: 2013年1月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
134

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Adults with COPD, confirmed by incompletely reversible airflow obstruction (post bronchodilator FEV1 <80% predicted and FER <0.7 or physician confirmed COPD in patients with a reduced FVC), and stable disease with no recent respiratory infection, acute exacerbation, or change in maintenance therapy in the previous 4 weeks. Participants will have a history of a prior COPD exacerbation in the past year.

排除标准

  • Current smoking (confirmed by history and exhaled carbon monoxide); current treatment with any macrolide, tetracycline or OCS in the preceding month, hypersensitivity to macrolides, pregnancy/breast feeding, inability to attend study visits, impaired liver function at screening as shown by AST, ALT, alkaline phosphatase or total bilirubin greater than the 2 times upper limit of normal. Participants will be excluded if there is prolongation of the QTc interval (480mS) or significant hearing impairment.

研究者

相似试验